170 related articles for article (PubMed ID: 1671187)
1. Preclinical pharmacology of celiprolol: a cardioselective beta-adrenergic antagonist and mild vasodilator.
Perrone MH; Barrett JA
Am Heart J; 1991 Feb; 121(2 Pt 2):677-83. PubMed ID: 1671187
[TBL] [Abstract][Full Text] [Related]
2. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
Pruss TP; Khandwala A; Wolf PS; Grebow P; Wong L
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of vasodilatory beta-blocking drugs.
Shanks RG
Am Heart J; 1991 Mar; 121(3 Pt 2):1006-11. PubMed ID: 1671724
[TBL] [Abstract][Full Text] [Related]
4. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat.
Alvarez-Guerra M; Alda O; Garay RP
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
Jolly SR; Smith RD; Wolf PS; Russ TP
Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
[TBL] [Abstract][Full Text] [Related]
6. Qualities of an ideal beta-adrenoceptor antagonist and comparison of existing agents with a new cardioselective hydrophilic vasodilator beta-adrenoceptor antagonist, celiprolol.
Opie LH
Am J Cardiol; 1988 Feb; 61(5):8C-13C. PubMed ID: 2893535
[TBL] [Abstract][Full Text] [Related]
7. Partial agonist activity of celiprolol, a cardioselective beta-antagonist.
Ochi S; Nakazawa M; Kimura T; Nakagawa Y; Imai S
Eur J Pharmacol; 1991 Feb; 194(1):1-5. PubMed ID: 1676370
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
Norris RJ
Am J Cardiol; 1988 Feb; 61(5):14C-22C. PubMed ID: 2893531
[TBL] [Abstract][Full Text] [Related]
9. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of celiprolol.
Louis WJ; Drummer OH; Tung LH
Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1281-5. PubMed ID: 1672604
[TBL] [Abstract][Full Text] [Related]
11. Celiprolol, a potent cardioselective beta 1-adrenoceptor antagonist with mild alpha 2-adrenoceptor antagonist properties.
Wolf PS; Pruss TP; Rand MJ; Smith RD; Mann WS; Romano DV
J Hypertens Suppl; 1985 Dec; 3(3):S195-7. PubMed ID: 2908816
[TBL] [Abstract][Full Text] [Related]
12. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
Silke B; Guy S; Riddell JG
J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
[TBL] [Abstract][Full Text] [Related]
13. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
Pittner H
Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
[TBL] [Abstract][Full Text] [Related]
14. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
Smith RD; Barrett JA; Wolf PS; Pruss TP
Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075
[No Abstract] [Full Text] [Related]
15. Effects of celiprolol in anesthetized dogs with reduced myocardial function.
Wolf PS; Smith RD; Barrett JA; Pruss TP
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S97-8. PubMed ID: 2427861
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
[TBL] [Abstract][Full Text] [Related]
17. Does the beta 1-adrenoceptor blocking agent celiprolol have alpha 2-adrenoceptor blocking properties?
Pittner H
Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):199-210. PubMed ID: 2883946
[TBL] [Abstract][Full Text] [Related]
18. Celiprolol and the heart.
Taylor SH
Am J Cardiol; 1988 Feb; 61(5):34C-40C. PubMed ID: 2893532
[TBL] [Abstract][Full Text] [Related]
19. Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients.
Pujet JC; Dubreuil C; Fleury B; Provendier O; Abella ML
Eur Respir J; 1992 Feb; 5(2):196-200. PubMed ID: 1348481
[TBL] [Abstract][Full Text] [Related]
20. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
van Zyl AI; Jennings AA; Bateman ED; Opie LH
Chest; 1989 Jan; 95(1):209-13. PubMed ID: 2562825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
